Neoglip Tablet 50mg / 500mg

About Neoglip Tablet 50mg / 500mg

Neoglip Tablet Uses

• Type 2 diabetes mellitus
• Blood sugar control when diet and exercise alone are not enough
• Combination therapy for patients not controlled on metformin alone

Neoglip Tablet Benefits

• Combines two complementary mechanisms in a single tablet
• Improves both fasting and after meal blood sugar levels
• Fewer tablets needed compared to taking two separate medicines
• Supports long term glycemic control

What Experts Say

Pakistani physicians prescribe this sitagliptin and metformin combination when a single diabetes medicine no longer keeps blood sugar within target range. Metformin reduces glucose production by the liver, while sitagliptin helps the body release more insulin after meals, giving two complementary actions in one tablet.

Type 2 diabetes is highly prevalent among adults in Pakistan, and many patients eventually need more than one medicine to stay controlled. Physicians in Pakistan often move to this combination because it simplifies the pill schedule compared to taking two separate tablets, which can improve how consistently patients take their medicine.

Doctors in Pakistan monitor kidney function regularly in patients on this combination, since metformin needs to be adjusted or stopped if kidney function declines. Patients are also advised to pause the medicine briefly around procedures involving contrast dye and to report persistent stomach pain, which could signal a rare but serious complication.

Drug Class

• DPP-4 Inhibitor and Biguanide Combination
• Oral Hypoglycemic Agent

Neoglip Tablet 50mg / 500mg formula

• Sitagliptin 50mg + Metformin HCl 500mg

Available forms

• Tablet

How to use Neoglip Tablet 50mg / 500mg?

• Neoglip Tablet 50mg / 500mg is usually taken with meals as directed by your doctor.
• The tablet should be swallowed whole with a full glass of water.
• It should not be crushed or chewed.
• The same times each day help maintain consistent blood sugar control.
• Diet and exercise recommendations should continue alongside this medicine.

Drug Interactions

• Insulin or Sulfonylureas: Insulin or sulfonylureas combined with this medicine increase the risk of hypoglycemia.
• Iodinated Contrast Media: Iodinated contrast media used in imaging tests raise the risk of kidney related complications, so a temporary pause is advised.
• Alcohol: Alcohol increases the risk of lactic acidosis and low blood sugar.
• Diuretics: Diuretics may affect kidney function and metformin clearance.
• Corticosteroids: Corticosteroids can raise blood sugar and reduce this medicine's effectiveness.

Risks and warnings

• Lactic Acidosis: A rare but serious risk of lactic acidosis is more likely with kidney impairment or dehydration.
• Kidney Function: Kidney function tests before and during treatment are generally recommended.
• Hypoglycemia: The risk of low blood sugar increases when combined with insulin or sulfonylureas.
• Pancreatitis: Severe stomach pain during treatment needs prompt medical attention.
• Contrast Dye Procedures: Imaging tests using iodinated contrast may require a temporary pause in this medicine.
• Vitamin B12: Long term use may lower vitamin B12 levels.

Neoglip Tablet Side Effects

• Nausea
• Diarrhea
• Stomach upset
• Headache
• Decreased appetite
• Metallic taste in the mouth
• Upper respiratory tract symptoms
• Low blood sugar when combined with other diabetes medicines

Storage Conditions

• Store below 30 degrees Celsius in a cool dry place.
• Keep the tablets in their original packaging until use.
• Protect from moisture and direct sunlight.
• Keep out of reach of children.